176 related articles for article (PubMed ID: 11930195)
1. Small cell lung cancer with positive anti-Hu antibodies presenting as gastroparesis.
Moskovitz DN; Robb KV
Can J Gastroenterol; 2002 Mar; 16(3):171-4. PubMed ID: 11930195
[TBL] [Abstract][Full Text] [Related]
2. Gastroparesis, pseudoachalasia and impaired intestinal motility as paraneoplastic manifestations of small cell lung cancer.
Hejazi RA; Zhang D; McCallum RW
Am J Med Sci; 2009 Jul; 338(1):69-71. PubMed ID: 19506460
[TBL] [Abstract][Full Text] [Related]
3. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
[TBL] [Abstract][Full Text] [Related]
4. Severe paraneoplastic gastroparesis associated with anti-Hu antibodies preceding the manifestation of small-cell lung cancer.
Nguyen-tat M; Pohl J; Günter E; Manner H; Plum N; Pech O; Ell C
Z Gastroenterol; 2008 Mar; 46(3):274-8. PubMed ID: 18322883
[TBL] [Abstract][Full Text] [Related]
5. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.
Graus F; Keime-Guibert F; Reñe R; Benyahia B; Ribalta T; Ascaso C; Escaramis G; Delattre JY
Brain; 2001 Jun; 124(Pt 6):1138-48. PubMed ID: 11353730
[TBL] [Abstract][Full Text] [Related]
6. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
Graus F; Dalmou J; Reñé R; Tora M; Malats N; Verschuuren JJ; Cardenal F; Viñolas N; Garcia del Muro J; Vadell C; Mason WP; Rosell R; Posner JB; Real FX
J Clin Oncol; 1997 Aug; 15(8):2866-72. PubMed ID: 9256130
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
Lucchinetti CF; Kimmel DW; Lennon VA
Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251
[TBL] [Abstract][Full Text] [Related]
8. Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies).
Toepfer M; Schroeder M; Unger JW; Lochmüller H; Pongratz D; Müller-Felber W
Clin Neurol Neurosurg; 1999 Sep; 101(3):207-9. PubMed ID: 10536910
[TBL] [Abstract][Full Text] [Related]
9. [Dysphagia and constipation as clinical manifestations of anti-Hu paraneoplastic syndrome].
Guardiola H; Vilaseca B; Martí S; de la Torre N
Med Clin (Barc); 2004 Sep; 123(10):398-9. PubMed ID: 15482710
[No Abstract] [Full Text] [Related]
10. Small cell lung cancer associated with anti-Hu paraneoplastic sensory neuropathy and peripheral nerve microvasculitis: case report and literature review.
Ansari J; Nagabhushan N; Syed R; Bomanji J; Bacon CM; Lee SM
Clin Oncol (R Coll Radiol); 2004 Feb; 16(1):71-6. PubMed ID: 14768759
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor.
Keime-Guibert F; Graus F; Broët P; Reñé R; Molinuevo JL; Ascaso C; Delattre JY
Neurology; 1999 Nov; 53(8):1719-23. PubMed ID: 10563618
[TBL] [Abstract][Full Text] [Related]
12. Anti-Hu Antibody-associated Paraneoplastic Neurological Syndrome Showing Peripheral Neuropathy and Atypical Multifocal Brain Lesions.
Shibata M; Uchida M; Tsukagoshi S; Yamaguchi K; Yamaguchi A; Furuta N; Makioka K; Maeno T; Fujita Y; Kurabayashi M; Ikeda Y
Intern Med; 2015; 54(23):3057-60. PubMed ID: 26631892
[TBL] [Abstract][Full Text] [Related]
13. [Abdominal complaints and neurological symptoms as an early sign of lung cancer: a manifestation of the anti-Hu syndrome].
Wymenga AN; Slebos DJ; van der Naalt J; van Putten JW; Peters FT
Ned Tijdschr Geneeskd; 2003 Mar; 147(13):616-9. PubMed ID: 12701397
[TBL] [Abstract][Full Text] [Related]
14. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
[TBL] [Abstract][Full Text] [Related]
15. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer.
Douglas CA; Ellershaw J
Palliat Med; 2003 Oct; 17(7):638-9. PubMed ID: 14594156
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies.
Condom E; Vidal A; Rota R; Graus F; Dalmau J; Ferrer I
Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):507-11. PubMed ID: 8291223
[TBL] [Abstract][Full Text] [Related]
17. [Disordered higher functions in a smoker].
Rakotomizao J; Barlési F; Lima G; Doddoli C; Gimenez C; Palot A; Kleisbauer JP
Rev Mal Respir; 2004 Jun; 21(3 Pt 1):595-8. PubMed ID: 15292854
[TBL] [Abstract][Full Text] [Related]
18. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer.
Verschuuren JJ; Perquin M; ten Velde G; De Baets M; Vriesman PB; Twijnstra A
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):353-7. PubMed ID: 10449558
[TBL] [Abstract][Full Text] [Related]
19. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract.
Schuffler MD; Baird HW; Fleming CR; Bell CE; Bouldin TW; Malagelada JR; McGill DB; LeBauer SM; Abrams M; Love J
Ann Intern Med; 1983 Feb; 98(2):129-34. PubMed ID: 6297344
[TBL] [Abstract][Full Text] [Related]
20. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
